Cancer heterogeneity

Chair: Mariam Jamal-Hanjani, University College London Cancer Institute, UK
Speaker: Peter Van Loo, The Francis Crick Institute, UK
Speaker: Samra Turajlic, The Francis Crick Institute, UK
Speaker: Trevor Graham, Barts Cancer Institute, UK


Room: Lomond Auditorium

This session should cover the background and add to the existing evidence for intratumour heterogeneity across different cancer types, in terms of tumour genomics and features of the tumour microenvironment, as well as the potential clinical implications of such heterogeneity in terms of therapeutic response and patient outcome. Deciphering the tumour genomic landscape relies on complex bioinformatics approaches, and so this session will also discuss the different approaches that can characterise and track tumour evolution dynamics using computational and integrative genomics.
Clinicians and scientists with an interest in tumour heterogeneity, evolutionary biology and bioinformatics analyses involving deep sequencing data should be drawn to this session.